US Patent Issued to Epizyme on July 28 for "SETD2 inhibitors and related methods and uses, including combination therapies" (Massachusetts Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,111, issued on July 28, was assigned to Epizyme Inc. (Cambridge, Mass.).

"SETD2 inhibitors and related methods and uses, including combination therapies" was invented by Maria Alejandra Raimondi (Jamaica Plain, Mass.), Jennifer Anne Totman (Berlin, Mass.), Vinny Motwani (Boston), Katherine Louise Cosmopoulos (Medford, Mass.) and John Lampe (Norfolk, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides SETD2 protein inhibitors, and methods, compositions, and kits for treating diseases, disorders, or conditions in a subject with a SETD2 protein inhibitor and, optionally, a second therapeutic agent, wherein the second th...